* Progyny Inc PGNY.OQ PGNY.O is expected to show a rise
in
quarterly revenue when it reports results on February 27.
* The New York City-based company is expected to report a
66.0% increase in revenue to $211.779 million from $127.55
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. The company's guidance on
November 28 2022, for the period ended December 31, was for
revenue between $208.90 million and $213.90 million.
* Refinitiv's mean analyst estimate for Progyny Inc is for
earnings of 1 cent per share. The company's EPS guidance on
November 28 2022, for the period ended December 31, was between
$0.02 and $0.03
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Progyny Inc
is
$47, above its last closing price of $30.57.
The company's guidance on November 28 2022 for the period ended
December 31 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between USD208.9 million and
USD32.86 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.06 0.05 0.13 Beat 175.8
Jun. 30 2022 0.02 0.05 0.09 Beat 100
Mar. 31 2022 0.00 0.01 0.05 Beat 525
Dec. 31 2021 0.04 0.04 0.15 Beat 316.7
Sep. 0.06 0.06 0.17 Beat 175.1
30 2021
Jun. 30 2021 0.08 0.08 0.19 Beat 131.7
Mar. 31 2021 0.08 0.08 0.15 Beat 93.1
Dec. 31 2020 0.05 0.06 0.01 Missed -82.1
This summary was machine generated February 25 at 03:09 GMT.
All figures in US dollars unless otherwise stated